EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Estetrol Enhances Mitochondrial Bioenergetics and Neurite Outgrowth in Cellular Models of Alzheimer’s Disease

Amandine Grimm iD, Aurélien Riou iD, Clara Gaillard, Aline Broeglin, Rodrigo Portes Ureshino iD, Valérie Dion, Céline Gérard, Anne Eckert iD

Cells · 03.03.2026 · 15 (5) · 452

DOI: 10.3390/cells15050452 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 03.03.2026. Verfasst von Amandine Grimm und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Cluster Molecular & Cognitive Neuroscience, Department of Biomedicine, University of Basel, 4002 Basel, Switzerland. Hauptthemen laut MEDLINE: Alzheimer Disease, Mitochondria, Energy Metabolism, Neuronal Outgrowth. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Estetra SRL, Freiwillige Akademische Gesellschaft (FAG) Basel, Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial dysfunction is an early driver of Alzheimer’s disease (AD), and the decline in sex hormones, including 17β-estradiol (E2), at menopause has been linked to AD risk in women. While E2 exerts potent neuroprotective and mitochondrial-regulatory effects, its clinical utility in estrogen replacement therapy (ERT) may be limited by thrombotic and oncologic risks. Estetrol (E4), a fetal estrogen with a selective safety profile, may represent a promising alternative. This study evaluated the impact of E4 on mitochondrial bioenergetics and neuronal morphology in human SH-SY5Y neuroblastoma cells, including models of AD-related amyloidopathy (amyloid precursor protein overexpression) and tauopathy (P301Ltau mutation overexpression). E4 significantly enhanced ATP levels, mitochondrial membrane potential, and oxidative respiration in all cell models, notably outperforming E2 in P301L cells. E4 also promoted significant neurite outgrowth, alleviating deficits observed in AD models. In addition, we demonstrated that the bioenergetic effects of E4 were mediated by the estrogen receptors ERα, ERβ, and GPER1. Furthermore, E4 modulated the expression of key mitochondrial genes, specifically upregulating the phosphate carrier SLC25A23 while downregulating the complex I subunit NDUFA1. In conclusion, E4 improves mitochondrial health and supports neuronal integrity via a multi-receptor mechanism, highlighting its potential as a safe neuroprotective therapy for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMitochondriaEnergy MetabolismNeuronal OutgrowthModels, BiologicalHumansCell Line, TumorMembrane Potential, MitochondrialReceptors, EstrogenEstradiol

Stichwörter der Autor:innen

Alzheimer’s diseaseamyloid-βbioenergeticsestetrol (E4)estradiol (E2)estrogen receptorsmitochondrianeurite outgrowthtau protein

Substanzen

Receptors, EstrogenEstradiol

Autor:innen und Institutionen

  • Research Cluster Molecular & Cognitive Neuroscience, Department of Biomedicine, University of Basel, 4002 Basel, Switzerland.
  • Neurobiology Laboratory for Brain Aging and Mental Health, Psychiatric University Clinics Basel (UPK), 4002 Basel, Switzerland.
  • Department of Biological Sciences, Federal University of Sao Paulo, Diadema 09972-270, SP, Brazil.
  • Laboratory of Molecular and Translational Endocrinology, Escola Paulista de Medicina, Federal University of Sao Paulo, Sao Paulo 04039-22, SP, Brazil.
  • Estetra SRL, a Wholly Owned Subsidiary of Gedeon Richter Plc., 4000 Liège, Belgium.

ORCID-Profile: Amandine Grimm, Aurélien Riou, Rodrigo Portes Ureshino, Anne Eckert

Förderung

  • Estetra SRL
  • Freiwillige Akademische Gesellschaft (FAG) Basel
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
  • Gedeon Richter, the Freiwillige Akademische Gesellschaft (FAG) Basel

Zitieren

APA

Grimm, A., Riou, A., Gaillard, C., Broeglin, A., Ureshino, R. P., Dion, V., Gérard, C., & Eckert, A. (2026). Estetrol Enhances Mitochondrial Bioenergetics and Neurite Outgrowth in Cellular Models of Alzheimer’s Disease. Cells, 15(5), 452. https://doi.org/10.3390/cells15050452

Vancouver

Grimm A, Riou A, Gaillard C, Broeglin A, Ureshino RP, Dion V, et al. Estetrol Enhances Mitochondrial Bioenergetics and Neurite Outgrowth in Cellular Models of Alzheimer’s Disease. Cells. 2026;15(5):452. doi:10.3390/cells15050452

BibTeX
@article{Grimm2026,
  author = {Grimm, Amandine and Riou, Aurélien and Gaillard, Clara and Broeglin, Aline and Ureshino, Rodrigo Portes and Dion, Valérie and Gérard, Céline and Eckert, Anne},
  title = {Estetrol Enhances Mitochondrial Bioenergetics and Neurite Outgrowth in Cellular Models of Alzheimer’s Disease},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {5},
  pages = {452},
  doi = {10.3390/cells15050452}
}
Kostenlos starten →